Literature DB >> 11288969

Implications of the absence of ST-segment elevation in lead V4R in patients who have inferior wall acute myocardial infarction with right ventricular involvement.

M Kosuge1, K Kimura, T Ishikawa, Y Hongo, T Shigemasa, M Sugiyama, O Tochikubo, S Umemura.   

Abstract

BACKGROUND: ST-segment elevation of > or = 1.0 mm in lead V4R has been shown to be a reliable marker of right ventricular involvement (RVI), a strong predictor of a poor outcome in patients with inferior acute myocardial infarction (IMI). However, patients with no ST-segment elevation in lead V4R despite the presence of RVI have received little attention. HYPOTHESIS: The study was undertaken to study the clinical features of patients with no ST-segment elevation in lead V4R despite the presence of RVI, which means false negative, as such patients have received little attention in the past.
METHODS: We studied 62 patients with a first IMI, who had total occlusion of the right coronary artery (RCA) proximal to the first right ventricular branch and successful reperfusion within 6 h from symptom onset, to examine the implications of the absence of ST-segment elevation in lead V4R despite the presence of RVI.
RESULTS: A standard 12-lead electrocardiogram (ECG) and right precordial ECG (lead V4R) were recorded on admission, and three posterior chest ECGs (leads V7 to V9) were additionally recorded in 34 patients. Patients were classified according to the absence (Group 1, n = 18) or presence (Group 2, n = 44) of ST-segment elevation of > or = 1.0 mm in lead V4R on admission. Patients in Group 1 had a greater ST-segment elevation in leads V7 to V9 (2.9+/-2.4 vs. 1.4+/-3.0 mm. p < 0.05), a higher frequency of a dominant RCA (defined as the distribution score > or = 0.7) (72 vs. 11%, p < 0.001), and a higher peak creatine kinase level (3760+/-1548 vs. 2809+/-1824 mU/ml, p < 0.05) than those in Group 2.
CONCLUSIONS: In patients with IMI caused by the occlusion of the RCA proximal to the first right ventricular branch, no ST-segment elevation in lead V4R can occur because of concomitant posterior involvement. In such patients, the incidence of RVI may be underestimated on the basis of ST-segment elevation in lead V4R.

Entities:  

Mesh:

Year:  2001        PMID: 11288969      PMCID: PMC6655134          DOI: 10.1002/clc.4960240310

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  Acute myocardial infarction with ST segment elevation in inferior and anterior leads: right ventricular infarction.

Authors:  Robert Berent; Johann Auer; Serge von Duvillard; Helmut Sinzinger; Dietmar Steinbrenner; Peter Schmid
Journal:  BMJ Case Rep       Date:  2010-01-13

2.  Clinical implications of precordial ST-segment elevation in acute inferoposterior myocardial infarction caused by proximal right coronary artery occlusion.

Authors:  Man-Hong Jim; Annie On-On Chan; Chun-Pong Wong; Kai-Hang Yiu; Raymond Miu; Stephen Wai-Luen Lee; Chu-Pak Lau
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

3.  Aberrant right coronary artery origin from the left aortic sinus with interarterial course manifesting acute myocardial infarction.

Authors:  Andreas Y Andreou; Marios A Ioannides; Panayiotis C Avraamides; George M Georgiou
Journal:  Exp Clin Cardiol       Date:  2009

4.  New criteria based on ST changes in 12-lead surface ECG to detect proximal versus distal right coronary artery occlusion in a case of acute inferoposterior myocardial infarction.

Authors:  Miquel Fiol; Andrés Carrillo; Iwona Cygankiewicz; José Ayestarán; Onofre Caldés; Vicente Peral; Armando Bethencourt; Wojciech Zareba; Antoni Bayés de Luna
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

5.  The relation of ST segment deviations in 12-lead conventional Electrocardiogram, right and posterior leads with the site of occlusion in acute inferior myocardial infarction.

Authors:  Shahrokh Karbalaie; Kaveh Hosseini; Ali Bozorgi
Journal:  Med J Islam Repub Iran       Date:  2014-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.